// App-Quantinova.ai

TCT-315 : Stent fracture and peri-stent contrast staining after everolimus-eluting stent implantation: 5-year clinical outcome

Researchers

Presenter

  • Katsuya Miura

Principal Investigators

  • Kazushige Kadota

  • Akimune Kuwayama

  • Masanobu Ohya

  • Takenobu Shimada

  • Hidewo Amano

  • Shunsuke Kubo

  • Yusuke Hyodo

  • Suguru Otsuru

  • Seiji Habara

  • Takeshi Tada

Medical Centers

  • Kurashiki Central Hospital, Kurashiki, Japan

  • Kurashiki Central Hospital, Kurashiki, Japan

  • Kurashiki Central Hospital, Okayama, Japan

  • Kurashiki City, Japan

  • Kurashiku, Okayama, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • sirolimus

  • Everolimus

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved